Litigation Details for Allergan Sales LLC v. Aurobindo Pharma USA Inc. (D. Del. 2018)
✉ Email this page to a colleague
Allergan Sales LLC v. Aurobindo Pharma USA Inc. (D. Del. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-01-19 |
Court | District Court, D. Delaware | Date Terminated | 2018-09-13 |
Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
Jury Demand | None | Referred To | |
Patents | 6,545,040 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Allergan Sales LLC v. Aurobindo Pharma USA Inc.
Details for Allergan Sales LLC v. Aurobindo Pharma USA Inc. (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2018-09-13 | 21 | Stipulation of dismissal | Aurobindo with infringement of U.S. Patent No. 6,545,040 (“the ’040 Patent”) in connection with Aurobindo’… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments:…expiration of the ’040 Patent was a technical act of infringement of that patent under 35 U.S.C. § 271…Court has subject matter jurisdiction over this patent infringement action (the “Action”) and personal…Aurobindo and any of the Plaintiffs regarding the ’040 Patent and/or a generic nebivolol hydrochloride product | External link to document |
2018-01-18 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,545,040 B1. (fms) (Entered:… 13 September 2018 1:18-cv-00118 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |